(Q34431929)

2 August 2017

title

Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A. (English)

1 reference

2 August 2017

F Yadao

1

1 reference

2 August 2017

P Hechtman

series ordinal

2

1 reference

2 August 2017

F Kaplan

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

Biochimica et Biophysica Acta

2 August 2017

published in

1 reference

2 August 2017

volume

1340

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

45-52

1 reference

Molecular cloning of a human co-beta-glucosidase cDNA: evidence that four sphingolipid hydrolase activator proteins are encoded by single genes in humans and rats

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Structure of full-length cDNA coding for sulfatide activator, a Co-beta-glucosidase and two other homologous proteins: two alternate forms of the sulfatide activator

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Coding of two sphingolipid activator proteins (SAP-1 and SAP-2) by same genetic locus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Mapping of the gene coding for the human GM2 activator protein to chromosome 5

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical and immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

The mechanism for a 33-nucleotide insertion in mRNA causing sphingolipid activator protein (SAP-1)-deficient metachromatic leukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

The protein activator specific for the enzymic hydrolysis of GM2 ganglioside in normal human brain and brains of three types of GM2 gangliosidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

A mutation in the gene of a glycolipid-binding protein (GM2 activator) that causes GM2-gangliosidosis variant AB

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Molecular genetics of GM2-gangliosidosis AB variant: a novel mutation and expression in BHK cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

A protein activator of galactosylceramide beta-galactosidase.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

The Activator of Cerebroside Sulphatase. Purification from Human Liver and Identification as a Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Identity of the activator proteins for the enzymatic hydrolysis of sulfatide, ganglioside GM1, and globotriaosylceramide

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

The activator of cerebroside sulphatase binding studies with enzyme and substrate demonstrating the detergent function of the activator protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

The activator of cerebroside-sulphatase. A model of the activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Activator proteins and topology of lysosomal sphingolipid catabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Complexing of Glycolipids and Their Transfer between Membranes by the Activator Protein for Degradation of Lysosomal Ganglioside GM2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Substrate binding properties of the human liver hexosaminidase A activator protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

The use of Sep-Pak C18 cartridges during the isolation of gangliosides

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

GM2 ganglioside in fetal Tay-Sachs disease brain cultures: a model system for the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Identification of candidate active site residues in lysosomal beta-hexosaminidase A.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

Isolation and expression of a full-length cDNA encoding the human GM2 activator protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

The purification of eukaryotic polypeptides synthesized in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2897%2900027-7

7 January 2021

10.1016/S0167-4838(97)00027-7

Identifiers

DOI

1 reference

2 August 2017

1 reference